1.CD44 and MMP14 Expression Associated with WHO Grade of the Astrocytoma and the Prognostic Implications.
Jaekyung MYUNG ; Bogun JANG ; Heae Surng PARK ; Woongjae YON ; Hyun Ju LEE ; Sung Hye PARK
Korean Journal of Pathology 2010;44(1):35-41
BACKGROUND: CD44 is a cell surface receptor that has been implicated in tumor cell invasion and metastasis in a range of tumors of various organs, including breast, ovary, colon, lung, and brain. CD44 stimulates the invasive ability by interacting with matrix metalloproteinase 14 (MMP14). The expression of MMP14 on the cell surface is thought to trigger multiple proteinase cascades and to stimulate cell migration. METHODS: A total 54 astrocytoma patients were eligible for this study. We performed a retrospective clinicopathological review and CD44 and MMP14 immunohistochemistry. RESULTS: The expressions of CD44 and MMP14 were significantly correlated with the World Health Organization (WHO) grade. On univariate analysis, the WHO grade and the expression of CD44 were the significant prognostic factors affecting overall survival (OS) and disease progression free survival (DPFS). On the multivariate analysis by the Cox regression model, the only WHO grade was shown to be a significant independent prognostic factor for predicting the DPFS and OS. CONCLUSIONS: In this study, the CD44 and MMP14 expressions were related to the WHO grade of astrocytoma. The CD44 expression status was a prognostic factor for DPFS and OS on univariate analysis, but it was not an independent prognostic factor on the multivariate analysis.
Antigens, CD44
;
Astrocytoma
;
Brain
;
Breast
;
Colon
;
Disease Progression
;
Female
;
Humans
;
Lung
;
Matrix Metalloproteinase 14
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Ovary
;
Prognosis
;
Retrospective Studies
;
World Health Organization
2.Suppression of the ERK–SRF axis facilitates somatic cell reprogramming
Sejong HUH ; Hwa Ryung SONG ; Geuk Rae JEONG ; Hyejin JANG ; Nan Hee SEO ; Ju Hyun LEE ; Ji Yeun YI ; Byongsun LEE ; Hyun Woo CHOI ; Jeong Tae DO ; Jin Su KIM ; Soo Hong LEE ; Jae Won JUNG ; Taekyu LEE ; Jaekyung SHIM ; Myung Kwan HAN ; Tae Hee LEE
Experimental & Molecular Medicine 2018;50(2):e448-
The molecular mechanism underlying the initiation of somatic cell reprogramming into induced pluripotent stem cells (iPSCs) has not been well described. Thus, we generated single-cell-derived clones by using a combination of drug-inducible vectors encoding transcription factors (Oct4, Sox2, Klf4 and Myc) and a single-cell expansion strategy. This system achieved a high reprogramming efficiency after metabolic and epigenetic remodeling. Functional analyses of the cloned cells revealed that extracellular signal-regulated kinase (ERK) signaling was downregulated at an early stage of reprogramming and that its inhibition was a driving force for iPSC formation. Among the reprogramming factors, Myc predominantly induced ERK suppression. ERK inhibition upregulated the conversion of somatic cells into iPSCs through concomitant suppression of serum response factor (SRF). Conversely, SRF activation suppressed the reprogramming induced by ERK inhibition and negatively regulated embryonic pluripotency by inducing differentiation via upregulation of immediate early genes, such as c-Jun, c-Fos and EGR1. These data reveal that suppression of the ERK-SRF axis is an initial molecular event that facilitates iPSC formation and may be a useful surrogate marker for cellular reprogramming.